Biopharmaceutical stocks that have lagged behind the broader market may finally have their day in the sun. BofA Securities ...

In a report released today, Tim Anderson from Bank of America Securities maintained a Sell rating on Amgen (AMGN – Research Report), with a ...

Having overcome off-field issues that affected his play, the former All-Star shortstop, in camp on a minor-league contract, ...

In a report released yesterday, Tim Anderson from Bank of America Securities maintained a Buy rating on Mineralys Therapeutics, Inc. (MLYS – ...

In a report released today, Tim Anderson from Bank of America Securities maintained a Buy rating on Gilead Sciences (GILD – Research Report), ...

TEMPE, Ariz. — A good redemption story is enticing. With Tim Anderson, it is also complicated. The veteran is in Angels camp this spring, forced to prove himself on a minor-league contract.